Atlas Trials

Segmentectomy vs Lobectomy for 2 - 3cm IASLC Grade 1-2 Lung Adenocarcinoma: A Multi-center RCT

Clinical trial NCT07169903 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07169903
Sponsor
Shanghai Pulmonary Hospital, Shanghai, China
Status
NOT_YET_RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Lung Adenocarcinoma
Start date
2025-10-01
Primary completion
2033-03-31
Enrollment
587

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.